openPR Logo
Press release

Global Cardiac Marker Testing Market strategically important analysis with top players like Medtronic, BD, Merck Group, LivaNova, Roche, Randox, Beckman Coulter, Quidel, Getinge, Siemens, Danaher Corporation, bioMérieux, Abcam, Inova Diagnostics

11-26-2018 01:19 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Cardiac Marker Testing share and trends

Cardiac Marker Testing share and trends

Cardiac Marker Testing market report delivers a detailed study with present and upcoming Opportunities to clarify the future investment and business plans of the market. The report contains complete analysis regarding type and applications, featuring the key business resources and provides an in-depth survey of top key vendors. This analysis gives an examination of various segments that are relied upon to witness the quickest development amid the estimate forecast frame. The Cardiac Marker Testing market study also analyzes the market status, share, growth rate, future trends, drivers, opportunities, challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The Global Cardiac Marker Testing Market is expected to reach USD 4.77 billion by 2025, from USD 2.48 billion in 2017 growing at a CAGR of 8.5% during the forecast period of 2018 to 2025.

Read Comprehensive Overview | Instantly Available At https://databridgemarketresearch.com/request-a-sample/?dbmr=global-cardiac-marker-testing-market

Major Companies Covered

Siemens, Danaher Corporation, bioMérieux, Ortho Clinical Diagnostics, Randox, Beckman Coulter, Quidel, Getinge, Medtronic, BD, Merck Group, LivaNova, Roche, Abcam, Inova Diagnostics, A Werfen Company, Abbott Diagnostics Business LSI, Bio-Rad Laboratories, LifeSign LLC, ZEUS Scientific ,ERBA Diagnostics, Inc., Medience Corporation, Guangzhou Wondfo Biotech Co., Ltd., MBL International Corporation, Merck KGaA, Darmstadt, Germany, HOB Biotech Group, Suzhou Lixinpharm Co.,Ltd, Human Diagnostics and others.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: PIPELINE ANALYSIS

• Pipeline analysis

PART 06: MARKET SIZING

• Market definition
• Market sizing
• Market size and forecast

PART 07: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 08: MARKET SEGMENTATION

• Segmentation
• Comparison
• Market opportunity

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

• Geographical segmentation
• Regional comparison
• North America
• South America
• Europe
• MEA
• APAC
• Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

• Overview
• Landscape disruption

PART 15: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors

PART 16: APPENDIX

• List of abbreviations

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Toc Is Available | Request At https://databridgemarketresearch.com/toc/?dbmr=global-cardiac-marker-testing-market

Market Drivers and Restraints

• Rapidly growing human population and their eagerness towards healthcare expenditure.

• The increasing cases of cardiovascular disease among the population.

• Increase in funding from private and government for R&D.

• Increasing Asia Pacific economy has quite a lot of opportunities.

• Stringent government norms and regulations for the use and approval of medical devices.

• Technical issues related to storage and collection of samples.

Key Developments

• In September 2018, LivaNova propelled an International Pivotal Study assessing utilization of autonomic control treatment for heart disappointment, demonstrating the company’s essence and commitment towards changing lives through the advancement and presentation of innovations, tending to the neglected needs in the worldwide restorative network.

• The investigation of cardiovascular biomarkers has turned into the principal line of indicative devices for AMI, empowering doctors in fast analysis and quick making arrangements for treatment, prompting diminished the death rate.

• Research at the Baylor College of Medicine revealed that, using diagnostic nanochips and a swab of the cheek, cardiac biomarker readings from saliva along with the ECG readings can determine within minutes if someone is likely to have had a heart attack.

Why Data Bridge Market Research?

• Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report.

• Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report.

• Inimitable Expertise: Analysts will provide deep insights about the reports

• Assured Quality: We focus on the quality and accuracy of the report

• Technically acclaimed Analysts with complete industry know how Robust research methodology followed by our publishers to arrive at market estimates, Focus on technology trends, Extensive repository of market research reports to meet our client’s needs.

• Based on extensive research, we provide clear view of real market scenario and help clients with making informed business decisions

GAIN EASY INQUIRY OF THIS REPORT, ALONG WITH ON-DEMAND SERVICES

Get Expert’s Insights at https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cardiac-marker-testing-market

Market Segmentation

Based on type,

• Troponin I and T,
• CK-MB,
• Myoglobin,
• Brain natriuretic peptide,
• C – Reactive protein, other biomarkers

The other biomarker segment is further segmented into

• Galectin-3,
• H-FABP,
• Myeloperoxidase,
• Ischemia-modified albumin, and
• Homocysteine

Based on product, the market is segmented into

• Instruments,
• chemiluminescence,
• Immunofluorescence,
• ELISA,
• immunochromatography and
• Reagents & kits

Based on disease, the market is segmented into

• Myocardial infarction and
• Congestive heart failure

Based on type of testing, the market is segmented into

• Laboratory testing and
• Point-of-care testing

By Geography

• Asia Pacific (China, South Korea, Japan, India, Australia, Singapore, Thailand, Indonesia, Malaysia, Philippines, Rest of Asia-Pacific).

• North America (US, Canada, Mexico).

• Europe (Russia, Turkey, Belgium, Netherlands, Switzerland, Spain, France, Germany, Italy, UK, Rest of Europe.

• South America (Brazil, Argentina, Rest of South America).

• Middle East and Africa (South Africa, Egypt, Saudi Arabia, United Arab Emirates, Israel, Rest of Middle East and Africa).

Customization of the Report:

This report can be customized to meet the client’s requirements. Please connect with our sales team (sopan.gedam@databridgemarketresearch.com), who will ensure that you get a report that suits your needs.

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cardiac Marker Testing Market strategically important analysis with top players like Medtronic, BD, Merck Group, LivaNova, Roche, Randox, Beckman Coulter, Quidel, Getinge, Siemens, Danaher Corporation, bioMérieux, Abcam, Inova Diagnostics here

News-ID: 1399014 • Views: 139

More Releases from Data Bridge Market Research

Radiotherapy Market is Booming Worldwide With CIVCO Medical Solutions, Brainlab …
Global Radiotherapy Market is expected to reach at a CAGR of 7.7% in the forecast period of 2018 to 2025. Global Radiotherapy Market, By Therapy (Beam Radiotherapy, Brachytherapy, Systemic Radiotherapy), By Product Type (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Softwares, Systemic Radiotherapy), By Application (Prostrate Cancer, Breast Cancer, Lung Cancer, Spine Cancer, Liver Cancer, Brain Cancer, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa) –
Cable Assembly Market Quantitative Analysis By TE Connectivity, Molex, LLC, W. L …
The cable assembly report aids in achieving an extreme sense of evolving industry movements before the competitors. This market research report gives clear idea about strategic analysis of mergers, expansions, acquisitions, partnerships, and investment. It becomes easy to analyse the actions of key players and its effect on the sales, import, export, revenue and CAGR values with this cable assembly report. The report is also a helpful source of assistance
Aroma Chemicals Market 2019:Quantitative Analysis By Hindustan Mint & Agro Produ …
The market analysis of aroma chemicals market report provides an examination of various market segments that are supposed to witness the fastest development amid the estimated forecast frame. A comprehensive market research has been conducted in this report which puts a light on the challenges, market structures, opportunities, driving forces, scope, and competitive landscape for your business. The best tools have been adopted to generate this report which is SWOT
Industrial Communication Market 2019:Industry Analysis By OMRON Corporation, Sch …
Global industrial communication market is set to witness a healthy CAGR of 11.12% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing adoption of industrial internet of things and increasing demand for wireless networks are the factor for the growth of this market. Industrial communication report is a well-generated market report which helps achieve comprehensive analysis of the market

All 5 Releases


More Releases for Cardiac

Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,
Ambulatory Cardiac Monitoring Devices
Ambulatory Cardiac Monitoring Devices Market by Product (Ambulatory Rhythm Monitor, Ambulatory ECG Monitor, Ambulatory Cardiac Event Monitor, Implantable Loop Recorder, Ambulatory real-time Cardiac Monitors, Cardiac Output Monitors); by End-User (Hospitals, Ambulatory Care Centers); by Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) –
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Stupendous Growth …
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are
Mexico Cardiac Assist Devices
Mexico Cardiac Assist Devices Overview "Mexico Cardiac Assist Devices Market Outlook to 2025", provides key market data on the Mexico Cardiac Assist Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices. Click here for sample report @ https://www.wiseguyreports.com/sample-request/3107735-mexico-cardiac-assist-devices-market-outlook-to-2025   Major Key Players: Abbott Laboratories Medtronic plc Getinge AB. Major Highlight of the report: The report also provides
Cardiac Monitoring & Cardiac Rhythm Management Market Review and Forecast 2025
Crystalmarketresearch.com published “Cardiac Monitoring & Cardiac Rhythm Management Market By Component, Technology, Application, And End User - Global Industry Analysis And Forecast To 2025” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. The cardiac monitoring & cardiac rhythm management market is expected to be worth $XX billion by 2025. The market is largely driven by factors such as rising incidence of cardiovascular
Cardiac Monitoring & Cardiac Rhythm Management Devices Market
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are